Coronavirus: Thread

[grarpamp]

As they say, curiously, both corona vax and this vax
were developed before their respective pandemics...

GeoVax Labs  Siga Tech

Biden Admin Places $119 Million Order For Monkeypox Vaccines As Virus Hits US

https://www.theepochtimes.com/biden-admin-places-119-million-order-for-vaccines-after-single-case-of-monkeypox-reported-in-us_4478604.html

https://www.fda.gov/news-events/press-announcements/fda-approves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypox
https://www.theepochtimes.com/us-confirms-monkeypox-virus-in-massachusetts-after-uk-spain-portugal-cases-in-men_4476197.html
https://www.bavarian-nordic.com/investor/news/news.aspx?news=6569
https://www.bavarian-nordic.com/investor/news/news.aspx?news=6574
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097449/
https://www.cdc.gov/poxvirus/monkeypox/symptoms.html
https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON383

The Biden administration has placed an order for millions of doses of
a vaccine intended to protect against smallpox and monkeypox, after
the first case of monkeypox in the United States this year was
confirmed in Massachusetts on May 18.
President Joe Biden delivers remarks in Buffalo, N.Y., on May 17,
2022. (Nicholas Kamm/AFP via Getty Images)

Monkeypox, a viral disease typically limited to Africa, has been
reported in several countries with more than 25 confirmed cases since
the beginning of May.

Denmark-based biotech group Bavarian Nordic announced the order on May
18, which prompts the company to convert its bulk liquid smallpox
vaccine into freeze-dried versions, which have an improved shelf life.
The bulk vaccine has already been manufactured and invoiced under
previous contracts with the U.S. government, the Bavarian Nordic
stated. The vaccine is approved under the name “JYNNEOS” in the United
States.

The order represents $119 million worth of the Jynneos vaccines, which
would be manufactured and invoiced in 2023 and 2024.

Under the contract, the Biden administration has the option to place
another order worth $180 million. That would allow for about 13
million freeze-dried doses of the Jynneos smallpox vaccine to be
manufactured by around 2024 and 2025. The majority of the bulk vaccine
for those doses has already been manufactured and invoiced, according
to the company.

Bavarian Nordic later announced on May 19 it will supply “an
undisclosed European country” with its smallpox vaccine. It is
approved under the name “IMVANEX” in Europe for smallpox, but has been
previously given off-label for monkeypox, the company said.

The U.S. Food and Drug Administration (FDA) approved the company’s
Jynneos vaccine in September 2019 for the prevention of smallpox and
monkeypox disease in people aged 18 and over. The vaccine would be
“available for those determined to be at high risk of either smallpox
or monkeypox infection.”

The FDA stated at the time, “This is the only currently FDA-approved
vaccine for the prevention of monkeypox disease.”

Peter Marks, director of the FDA’s Center for Biologics Evaluation and
Research, said at the time that “the intentional release” of smallpox,
a highly contagious virus, “could have a devastating effect.”

Bavarian Nordic President and CEO Paul Chaplin called the current
monkeypox situation in Europe one that “calls for a rapid and
coordinated approach by the health authorities,” adding that the
company is “pleased to assist in this emergency situation.”

The National Institute of Allergy and Infectious Diseases (NIAID) back
in 2004 had given Barvarian Nordic a $100 million contract for
research on a smallpox vaccine, as part of Project BioShield, a
government initiative to incentivize private companies to develop
vaccines and other countermeasures to deal with chemical, biological,
radiological, and nuclear threats.
Symptoms of one of the first known cases of the monkeypox virus are
shown on a patient’s hand May 27, 2003. (CDC/Getty Images)
Growing Cases of Monkeypox

According to the Centers for Disease Control and Prevention, monkeypox
in humans shows symptoms similar to smallpox, but milder. Those
infected may have fever, headache, muscle aches, and exhaustion, as
well as skin lesions that can last up to a month.

After fever onset, patients can also develop a rash that often starts
on the face and spreads to other parts of the body. Monkeypox causes
lymph nodes to swell while smallpox does not, the CDC states on its
website.

Authorities in multiple countries have reported that the vast majority
of cases involve men who have sex with other men, but have not yet
confirmed how people have been infected. The World Health Organization
says monkeypox “can be transmitted by droplet exposure via exhaled
large droplets and by contact with infected skin lesions or
contaminated materials.”

On May 7th, the very first case in the western world in 2022 was
confirmed in the United Kingdom.

Now here we are less than two weeks later and there are now dozens of
confirmed and suspected cases in twelve different countries outside of
Africa.